Tolerability of Lopinavir Versus Dolutegravir for Children and Adolescents Living With HIV

CompletedOBSERVATIONAL
Enrollment

258

Participants

Timeline

Start Date

July 11, 2022

Primary Completion Date

September 20, 2023

Study Completion Date

September 20, 2023

Conditions
HIV
Trial Locations (1)

Unknown

Baylor Center of Excellence Maseru, Maseru

All Listed Sponsors
collaborator

University Hospital, Basel, Switzerland

OTHER

collaborator

University of Basel

OTHER

collaborator

University of Zurich

OTHER

collaborator

Baylor International Pediatric AIDS Initiative

UNKNOWN

collaborator

Lesotho Ministry of Health

UNKNOWN

collaborator

Baylor College of Medicine Children's Foundation Lesotho

UNKNOWN

lead

Swiss Tropical & Public Health Institute

OTHER